Sylvie G. Bernier

2.1k total citations
47 papers, 1.7k citations indexed

About

Sylvie G. Bernier is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sylvie G. Bernier has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Physiology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sylvie G. Bernier's work include Nitric Oxide and Endothelin Effects (14 papers), Receptor Mechanisms and Signaling (11 papers) and Sphingolipid Metabolism and Signaling (8 papers). Sylvie G. Bernier is often cited by papers focused on Nitric Oxide and Endothelin Effects (14 papers), Receptor Mechanisms and Signaling (11 papers) and Sphingolipid Metabolism and Signaling (8 papers). Sylvie G. Bernier collaborates with scholars based in United States, Canada and Taiwan. Sylvie G. Bernier's co-authors include Thomas Michel, Junsuke Igarashi, Saptarsi M. Haldar, Gaétan Guillemette, Sylvain Chemtob, Xin Hou, Daya R. Varma, Gerhard Hannig, Martin Beauchamp and William Westlin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Sylvie G. Bernier

45 papers receiving 1.6k citations

Peers

Countries citing papers authored by Sylvie G. Bernier

Since Specialization

Citations

This map shows the geographic impact of Sylvie G. Bernier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie G. Bernier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie G. Bernier more than expected).

Fields of papers citing papers by Sylvie G. Bernier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie G. Bernier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie G. Bernier. The network helps show where Sylvie G. Bernier may publish in the future.

Co-authorship network of co-authors of Sylvie G. Bernier

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie G. Bernier. A scholar is included among the top collaborators of Sylvie G. Bernier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie G. Bernier. Sylvie G. Bernier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dietary flavonoids form supramolecular assemblies, alter biochemistry, and enhance cell resilience 2025 ·Frontiers in Nutrition ·(unknown), Sylvie G. Bernier, Sanjid Shahriar, Viktor Horváth, Michael Lewandowski, Emilia Javorsky, Bogdan Budnik, Donald E. Ingber	0
2	Broad-spectrum coronavirus inhibitors discovered by modeling viral fusion dynamics 2025 ·Frontiers in Molecular Biosciences ·(unknown), (unknown), (unknown), (unknown), Sylvie G. Bernier, Kenneth E. Carlson, Donald E. Ingber	0
3	Rapid discovery and evolution of nanosensors containing fluorogenic amino acids 2024 ·Nature Communications ·Erkin Kuru, Jonathan Rittichier, Helena de Puig, (unknown), (unknown), Isaac Han, (unknown), (unknown), Fabio De Moliner, Sylvie G. Bernier, Jason D. Galpin, Jorge A. Marchand, (unknown), Lindsey R. Robinson‐McCarthy, Christopher A. Ahern, Thomas G. Bernhardt, David Z. Rudner, James J. Collins, Marc Vendrell, George M. Church	4
4	Discovery of CYR715: A novel carboxylic acid-containing soluble guanylate cyclase stimulator 2021 ·Bioorganic & Medicinal Chemistry Letters ·Glen R. Rennie, Timothy C. Barden, Sylvie G. Bernier, (unknown), (unknown), (unknown), (unknown), G-Yoon Jamie Im, (unknown), (unknown), Joon Jung, (unknown), Thomas Lee, Ara H. Mermerian, (unknown), Takashi Nakai, Nicholas R. Perl, Jenny Tobin, Daniel P. Zimmer, Paul A. Renhowe	4
5	The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system 2021 ·Journal of Neuroinflammation ·(unknown), Guang Liu, Sarah Jacobson, Sylvie G. Bernier, Jenny Tobin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kim San Tang, (unknown), Mark G. Currie, John R. Hadcock, Christopher J. Winrow, Juli E. Jones	20
6	Social Interactions among Older Adults Who Wish for Death 2019 ·Clinical Gerontologist ·Sylvie G. Bernier, Sylvie Lapierre, Sophie Desjardins	21
7	Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1 2012 ·Bioorganic & Medicinal Chemistry Letters ·Ghotas Evindar, Hongfeng Deng, Sylvie G. Bernier, (unknown), (unknown), Barry A. Morgan, William Westlin	2
8	Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Ghotas Evindar, Alexander L. Satz, Sylvie G. Bernier, Malcolm J. Kavarana, (unknown), (unknown), (unknown), (unknown), Amy Hutchings, Michael S. P. Kelley, (unknown), Ashis Saha, Gerhard Hannig, Barry A. Morgan, William Westlin	6
9	Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI‐2458 2007 ·Arthritis & Rheumatism ·Gerhard Hannig, Sylvie G. Bernier, Jennifer Hoyt, (unknown), (unknown), Russell Karp, (unknown), William Westlin	20
10	Methionine aminopeptidases type I and type II are essential to control cell proliferation 2005 ·Journal of Cellular Biochemistry ·Sylvie G. Bernier, (unknown), Charles D. Thompson, William Westlin, Gerhard Hannig	59
11	A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis 2004 ·Proceedings of the National Academy of Sciences ·Sylvie G. Bernier, Douglas Lazarus, (unknown), (unknown), Matthew Labenski, Charles D. Thompson, William Westlin, Gerhard Hannig	84
12	Modulation of Pro-inflammatory Gene Expression by Nuclear Lysophosphatidic Acid Receptor Type-1 2003 ·Journal of Biological Chemistry ·Fernand Gobeil, Sylvie G. Bernier, Alejandro Vazquez‐Tello, Sonia Brault, Martin Beauchamp, Christiane Quiniou, Anne Marilise Marrache, Daniella Checchin, Florian Sennlaub, Xin Hou, Moni Nader, Ghassan Bkaily, Alfredo Ribeiro‐da‐Silva, Edward J. Goetzl, Sylvain Chemtob	119
13	Proinflammatory Gene Induction by Platelet-Activating Factor Mediated Via Its Cognate Nuclear Receptor 2002 ·The Journal of Immunology ·Anne Marilise Marrache, Fernand Gobeil, Sylvie G. Bernier, Jana Staňková, Marek Rola‐Pleszczynski, Sanaa Choufani, Ghassan Bkaily, Annie Bourdeau, Martin G. Sirois, Alejandro Vazquez‐Tello, Li Fan, Jean‐Sébastien Joyal, János G. Filep, Daya R. Varma, Alfredo Ribeiro‐da‐Silva, Sylvain Chemtob	102
14	Characterization of PGE2 receptors in fetal and newborn ductus arteriosus in the pig 2001 ·Seminars in Perinatology ·(unknown), Sylvie G. Bernier, Pierre Asselin, Pierre Hardy, Mousumi Bhattacharya, Christiane Quiniou, Jean‐Claude Fouron, Anne-Marie Guerguerian, Daya R. Varma, Ronald I. Clyman, Sylvain Chemtob	8
15	Sphingosine 1-Phosphate and Activation of Endothelial Nitric-oxide Synthase 2001 ·Journal of Biological Chemistry ·Junsuke Igarashi, Sylvie G. Bernier, Thomas Michel	224
16	Adenosine induces cyclic‐AMP formation and inhibits endothelin‐1 production/secretion in guinea‐pig tracheal epithelial cells through A_2B adenosine receptors 2000 ·British Journal of Pharmacology ·S. William Pelletier, Jean Y. Dubé, (unknown), Fernand Gobeil, Sylvie G. Bernier, Bruno Battistini, Gaétan Guillemette, Pierré Sirois	12
17	Monitoring of Phospholipase A2 Activation in Cultured Cells Using Tritiated Arachidonic Acid 1998 ·Humana Press eBooks ·(unknown), Sylvie G. Bernier, (unknown)	5
18	N- and C-terminal structure–activity study of angiotensin II on the angiotensin AT2 receptor 1998 ·European Journal of Pharmacology ·Richard Bouley, (unknown), (unknown), Lenka Řihakova, Sylvie G. Bernier, Lenka Maletı́nská, Gaétan Guillemette, Emanuel Escher	28
19	Desensitization of AT1 Receptor-Mediated Cellular Responses Requires Long Term Receptor Down-Regulation in Bovine Adrenal Glomerulosa Cells* 1997 ·Endocrinology ·Darren E. Richard, Stéphane A. Laporte, Sylvie G. Bernier, Richard Leduc, Gaétan Guillemette	18
20	A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes 1994 ·European Journal of Pharmacology ·Sylvie G. Bernier, Alain Fournier, Gaétan Guillemette	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact